Review

gfp rab8a q67l (Addgene inc)

Addgene inc is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Addgene inc gfp rab8a q67l
Gfp Rab8a Q67l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp+rab8a+q67l/pGFP-Rab8A%5BQ67L%5D+(Plasmid+%2324900)/pmc07298307-236-4-14
Average 93 stars, based on 5 article reviews

gfp rab8a q67l - by Bioz Stars, 2026-09

93/100 stars

Images

Plasmid Preparation:

Article Title: ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry
Article Snippet: Mutagenesis was performed using Quikchange (Stratagene) according to the manufacturer’s protocol. .. RFP-LAMP1 (plasmid #1817), RFP-EEA1 (plasmid #42635), GFP-Rab8a (plasmid #24898), GFP-Rab8a[Q67L] (plasmid #24900), and pcDNA-HA-Arf6 (plasmid # 10834) were obtained from Addgene. ..

Expressing:

Article Title: Insufficiency of ciliary cholesterol in hereditary Zellweger syndrome
Article Snippet: .. ECFP‐SKL (#54548), GFP‐Rab8A (#24898), GFP‐Rab8A‐Q67L (#24900), and tdTomato‐BicD2‐FKBP (#64205) expression vectors were purchased from Addgene. .. The PEX3‐GFP‐FRB expression vector for mammalian cells was constructed from PEX3‐GFP‐Halo (#67764; Addgene) and Mito‐mCherry‐FRB (#59352; Addgene) using PCR and the Gibson assembly kit (New England Biolabs).

Image Search Results

Active RAB8A and Rabin8 rescue the LRRK2-mediated deficit in EGF binding and degradation. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs followed by quantification of the amount of surface-bound fluorescent EGF. n = 4 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized Alexa555-EGF in transfected cells after 10 ( left ) and 30 min ( right ) of internalization. Values are normalized to the amount of Alexa555-EGF binding at t = 0. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs followed by quantification of internalized Alexa555-EGF after 10 ( left ) and 30 min ( right ) of internalization. n = 8 independent experiments. ****, p < 0.001. E , cells were transfected with either empty pCMV vector ( ctrl ) or with Rabin8, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. F , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. G , cells were transfected with either empty pCMV vector ( ctrl ) or cotransfected with G2019S pathogenic LRRK2 and either pCMV vector or Rabin8 as indicated, and surface-bound fluorescent EGF was quantified. n = 3 experiments. *, p < 0.05. H , cells were transfected as indicated followed by quantification of internalized fluorescent EGF as described above. n = 3 independent experiments. ***, p < 0.005. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Active RAB8A and Rabin8 rescue the LRRK2-mediated deficit in EGF binding and degradation. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs followed by quantification of the amount of surface-bound fluorescent EGF. n = 4 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized Alexa555-EGF in transfected cells after 10 ( left ) and 30 min ( right ) of internalization. Values are normalized to the amount of Alexa555-EGF binding at t = 0. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs followed by quantification of internalized Alexa555-EGF after 10 ( left ) and 30 min ( right ) of internalization. n = 8 independent experiments. ****, p < 0.001. E , cells were transfected with either empty pCMV vector ( ctrl ) or with Rabin8, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. F , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. G , cells were transfected with either empty pCMV vector ( ctrl ) or cotransfected with G2019S pathogenic LRRK2 and either pCMV vector or Rabin8 as indicated, and surface-bound fluorescent EGF was quantified. n = 3 experiments. *, p < 0.05. H , cells were transfected as indicated followed by quantification of internalized fluorescent EGF as described above. n = 3 independent experiments. ***, p < 0.005. All error bars represent S.E.M.

Article Snippet: Human GFP-RAB8A, GFP-RAB8A-Q67L, and GFP-RAB8A-T22N were gifts from Maxence Nachury (Addgene plasmids 24898, 24899, and 24900) , and GFP-RAB8A-T72A, GFP-RAB8A-T72D, and GFP-RAB8A-T72E were generated by site-directed mutagenesis (QuikChange, Stratagene).

Techniques: Binding Assay, Transfection, Plasmid Preparation, Construct

Phosphodeficient RAB8A, but not WT or phosphomimetic RAB8A variants, revert the LRRK2-mediated effects on EGFR trafficking. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 4 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were transfected with the indicated constructs, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 8 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Phosphodeficient RAB8A, but not WT or phosphomimetic RAB8A variants, revert the LRRK2-mediated effects on EGFR trafficking. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 4 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were transfected with the indicated constructs, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 8 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. All error bars represent S.E.M.

Techniques: Transfection, Plasmid Preparation, Construct

Knockdown of RAB8A mimics the endolysosomal trafficking deficits mediated by G2019S LRRK2. A , HeLa cells were either nontransfected (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels and tubulin as a loading control. B , quantification of the type of experiments depicted in A . RAB8A levels in the presence of RAB8A-siRNA were normalized to levels in the presence of ctrl-siRNA. n = 3 independent experiments. *, p < 0.05. C , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. D , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. **, p < 0.01; ****, p < 0.001. E , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of GFP-tagged active RAB7A (RAB7A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. F , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of RAB7A-Q67L, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. G , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and the RAB7-binding domain of RILP coupled to GST was used to pull down the GTP-bound form of RAB7 from cell lysates (300 μg). Input (10%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. H , experiments of the type depicted in G were quantified, and the amount of RAB7 isolated by GST-RILP was expressed relative to input. n = 3 independent experiments. ***, p < 0.005. I , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and a conformation-specific antibody was used to immunoprecipitate active RAB7 from cell lysates (2 mg). As a positive control, ctrl-siRNA–treated cell extracts were incubated with 100 μ m GTPγS to activate RAB7A before immunoprecipitation. Input (1%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Knockdown of RAB8A mimics the endolysosomal trafficking deficits mediated by G2019S LRRK2. A , HeLa cells were either nontransfected (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels and tubulin as a loading control. B , quantification of the type of experiments depicted in A . RAB8A levels in the presence of RAB8A-siRNA were normalized to levels in the presence of ctrl-siRNA. n = 3 independent experiments. *, p < 0.05. C , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. D , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. **, p < 0.01; ****, p < 0.001. E , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of GFP-tagged active RAB7A (RAB7A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. F , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of RAB7A-Q67L, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. G , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and the RAB7-binding domain of RILP coupled to GST was used to pull down the GTP-bound form of RAB7 from cell lysates (300 μg). Input (10%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. H , experiments of the type depicted in G were quantified, and the amount of RAB7 isolated by GST-RILP was expressed relative to input. n = 3 independent experiments. ***, p < 0.005. I , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and a conformation-specific antibody was used to immunoprecipitate active RAB7 from cell lysates (2 mg). As a positive control, ctrl-siRNA–treated cell extracts were incubated with 100 μ m GTPγS to activate RAB7A before immunoprecipitation. Input (1%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. All error bars represent S.E.M.

Techniques: Transfection, Western Blot, Binding Assay, Isolation, Positive Control, Incubation, Immunoprecipitation

Pathogenic LRRK2 or knockdown of RAB8A causes accumulation of EGF in a RAB4-positive endocytic compartment. A , HeLa cells were transfected with either empty pCMV vector or pathogenic LRRK2 or cotransfected with GFP-tagged RAB4, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 6 independent experiments. ***, p < 0.005. E , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA. Live pictures were taken as described above. Arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. F , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Pathogenic LRRK2 or knockdown of RAB8A causes accumulation of EGF in a RAB4-positive endocytic compartment. A , HeLa cells were transfected with either empty pCMV vector or pathogenic LRRK2 or cotransfected with GFP-tagged RAB4, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 6 independent experiments. ***, p < 0.005. E , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA. Live pictures were taken as described above. Arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. F , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. All error bars represent S.E.M.

Techniques: Transfection, Plasmid Preparation

Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to knockdown of RAB8A are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA in the presence or absence of distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01; ***, p < 0.005. C , HeLa cells were treated with ctrl-siRNA or RAB8A-siRNA as indicated and transfected with the indicated RAB7A constructs, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were treated with either ctrl-siRNA or RAB8A-siRNA as indicated with or without cotransfection with the indicated RAB7A constructs. EGFR recycling assays were performed as described under “Materials and methods,” revealing a deficit in EGFR surface levels and EGFR recycling upon RAB8A-siRNA, which was rescued upon expression of active RAB7A. n = 3 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to knockdown of RAB8A are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA in the presence or absence of distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01; ***, p < 0.005. C , HeLa cells were treated with ctrl-siRNA or RAB8A-siRNA as indicated and transfected with the indicated RAB7A constructs, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were treated with either ctrl-siRNA or RAB8A-siRNA as indicated with or without cotransfection with the indicated RAB7A constructs. EGFR recycling assays were performed as described under “Materials and methods,” revealing a deficit in EGFR surface levels and EGFR recycling upon RAB8A-siRNA, which was rescued upon expression of active RAB7A. n = 3 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Techniques: Expressing, Construct, Transfection, Western Blot, Cotransfection

Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to G2019S LRRK2 expression are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2 with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in cells coexpressing empty pCMV vector or G2019S LRRK2 in the presence or absence of mRFP-tagged RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. C , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for FLAG-tagged G2019S-LRRK2, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were transfected with either empty pCMV vector or pathogenic G2019S LRRK2 in the presence or absence of mRFP-tagged RAB7A constructs as indicated, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to G2019S LRRK2 expression are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2 with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in cells coexpressing empty pCMV vector or G2019S LRRK2 in the presence or absence of mRFP-tagged RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. C , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for FLAG-tagged G2019S-LRRK2, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were transfected with either empty pCMV vector or pathogenic G2019S LRRK2 in the presence or absence of mRFP-tagged RAB7A constructs as indicated, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Techniques: Expressing, Plasmid Preparation, Construct, Transfection, Western Blot

Expression of dominant-negative RAB7A causes defects in EGFR trafficking, accumulation of EGF in a RAB4-positive endocytic compartment, and deficits in EGFR recycling, which are reversed upon active RAB8A expression. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or with dominant-negative RAB7A (RAB7A-T22N) in the presence or absence of active RAB8A (RAB8A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either mRFP-RAB7A-T22N or mRFP-RAB7A-T22N and FLAG-tagged RAB8A-Q67L as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of the distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. E , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of RAB7A-T22N and RAB8A-Q67L constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. *, p < 0.05. F , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for mRFP-tagged RAB7A-T22N, FLAG-tagged RAB8A-Q67L, and GAPDH as a loading control. G , HeLa cells were transfected with either empty pCMV vector or dominant-negative RAB7A-T22N in the absence or presence of RAB8A-Q67L, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005. A.U. , arbitrary units. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Expression of dominant-negative RAB7A causes defects in EGFR trafficking, accumulation of EGF in a RAB4-positive endocytic compartment, and deficits in EGFR recycling, which are reversed upon active RAB8A expression. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or with dominant-negative RAB7A (RAB7A-T22N) in the presence or absence of active RAB8A (RAB8A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either mRFP-RAB7A-T22N or mRFP-RAB7A-T22N and FLAG-tagged RAB8A-Q67L as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of the distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. E , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of RAB7A-T22N and RAB8A-Q67L constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. *, p < 0.05. F , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for mRFP-tagged RAB7A-T22N, FLAG-tagged RAB8A-Q67L, and GAPDH as a loading control. G , HeLa cells were transfected with either empty pCMV vector or dominant-negative RAB7A-T22N in the absence or presence of RAB8A-Q67L, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005. A.U. , arbitrary units. All error bars represent S.E.M.

Techniques: Expressing, Dominant Negative Mutation, Transfection, Plasmid Preparation, Construct, Western Blot

Review

gfp rab8a q67l (Addgene inc)

Structured Review

Images

Related Articles

Plasmid Preparation:

Expressing:

Similar Products

Image Search Results